Literature DB >> 22462240

Dangfei liganning capsules attenuate the susceptibility of rat nonalcoholic fatty liver to carbon tetrachloride toxicity.

Hai-Yan Song1, Zhi-Min Mao, Li-Li Yang, Tao Liu, Dong-Fei Li, Li Zhang, Ying-Li Ge, Pei-Yong Zheng, Ping Liu, Xiao-Qi Zhang, Guang Ji.   

Abstract

OBJECTIVE: To test whether nonalcoholic hepatic steatosis sensitizes carbon tetrachloride (CCl4)-induced liver injury, and to assess the therapeutic effect of Chinese medicine extracts of Dangfei Liganning capsules and their potential underlying mechanisms.
METHODS: Male Wistar rats were fed a high-fat diet to induce nonalcoholic fatty liver disease (NAFLD) or a normal diet (N). Eight weeks later, a nonlethal dose of CCl4 was applied intraperitoneally. From the start, HF-CCl4 rats were administered daily Dangyao extracts (D), Dangfei Liganning capsules (DF), or Diammonium Glycyrrhizinate (G) intragastrically. Rats were sacrificed 48 h after CCl4 administration. In addition to serum biochemistry, liver histopathology was observed using hematoxylin-eosin (HE) and oil red O staining, and hepatic levels of triglyceride (TG), malondialdehyde (MDA), glutathione (GSH), superoxide dismutase (SOD), caspase-3 activation and cytochrome P450 (CYP2E1) expression were assessed.
RESULTS: There was almost no response to the nonlethal dose of CCl4 in the N control group. However, the HF group demonstrated massive steatosis, and elevated levels of serum ALT and AST, liver MDA, CYP2E1, and caspase-3 activation, whereas the levels of GSH and SOD were significantly decreased. All indexes assessed were dramatically worse in the HF-CCl4 group compared to the HF group, in addition to the more severe steatosis, hepatocyte ballooning, and inflammatory infiltration apparent in the centrilobular area. The medicines we tested affected the pathological changes in HF-CCl4 rats to differing degrees: DF and G led to improvements in all of the above examined indexes, including an obvious improvement in histopathology, and DF improved serum ALT and MDA levels more markedly than G, whereas D extracts produced only mild liver injury attenuation.
CONCLUSION: Liver with NAFLD is more sensitive to hepatotoxicity; furthermore, the disrupted balance of oxidative stress and anti-oxidant defense contributes to the underlying mechanisms. Dangfei Liganning capsules potentially decrease this toxic susceptibility and alleviate liver injury in non-alcoholic fatty liver.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22462240     DOI: 10.1016/s0254-6272(12)60013-2

Source DB:  PubMed          Journal:  J Tradit Chin Med        ISSN: 0255-2922            Impact factor:   0.848


  7 in total

1.  Preventive activity of banana peel polyphenols on CCl4-induced experimental hepatic injury in Kunming mice.

Authors:  Rui Wang; Xia Feng; Kai Zhu; Xin Zhao; Huayi Suo
Journal:  Exp Ther Med       Date:  2016-03-11       Impact factor: 2.447

Review 2.  Herbal medicines for the treatment of nonalcoholic steatohepatitis: current scenario and future prospects.

Authors:  Ravirajsinh Jadeja; Ranjitsinh V Devkar; Srinivas Nammi
Journal:  Evid Based Complement Alternat Med       Date:  2014-06-03       Impact factor: 2.629

3.  Rutin Attenuates Hepatotoxicity in High-Cholesterol-Diet-Fed Rats.

Authors:  Shakir D AlSharari; Salim S Al-Rejaie; Hatem M Abuohashish; Mohamed M Ahmed; Mohamed M Hafez
Journal:  Oxid Med Cell Longev       Date:  2016-04-27       Impact factor: 6.543

Review 4.  A Review of Western and Traditional Chinese Medical Approaches to Managing Nonalcoholic Fatty Liver Disease.

Authors:  Wei-Fan Hsu; Lee-Yan Sheen; Hung-Jen Lin; Hen-Hong Chang
Journal:  Evid Based Complement Alternat Med       Date:  2016-10-31       Impact factor: 2.629

5.  Jiang-Zhi granules decrease sensitivity to low-dose CCl4 induced liver injury in NAFLD rats through reducing endoplasmic reticulum stress.

Authors:  Lili Yang; Yan Zhou; Haiyan Song; Peiyong Zheng
Journal:  BMC Complement Altern Med       Date:  2019-08-22       Impact factor: 3.659

6.  Protective effect of rutin on the antioxidant genes expression in hypercholestrolemic male Westar rat.

Authors:  Salem S Al-Rejaie; Abdulaziz M Aleisa; Mohamed M Sayed-Ahmed; Othman A Al-Shabanah; Hatem M Abuohashish; Mohammed M Ahmed; Khaled A Al-Hosaini; Mohamed M Hafez
Journal:  BMC Complement Altern Med       Date:  2013-06-17       Impact factor: 3.659

Review 7.  Preclinical Models for Investigation of Herbal Medicines in Liver Diseases: Update and Perspective.

Authors:  Hor-Yue Tan; Serban San-Marina; Ning Wang; Ming Hong; Sha Li; Lei Li; Fan Cheung; Xiao-Yan Wen; Yibin Feng
Journal:  Evid Based Complement Alternat Med       Date:  2016-01-28       Impact factor: 2.629

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.